Glabridin is a species-specific biomarker from the roots Glycyrrhiza glabra L. (European licorice, Fabaceae). Stereochemical analysis, including circular dichroism, NMR data and an X-ray diffraction data set with Bijvoet differences, confirms that glabridin, purified from its natural source, is found only in a C3 R configuration.
Keywords: crystal structure, absolute configuration, glabridin, natural compounds
Abstract
The title compound {systematic name: 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol, commonly named glabridin}, C20H20O4, is a species-specific biomarker from the roots Glycyrrhiza glabra L. (European licorice, Fabaceae). In the present study, this prenylated isoflavan has been purified from an enriched CHCl3 fraction of the extract of the root, using three steps of medium-pressure liquid chromatography (MPLC) by employing HW-40F, Sephadex LH-20 and LiChroCN as adsorbents. Pure glabridin was crystallized from an MeOH–H2O mixture (95:5 v/v) to yield colorless crystals containing one molecule per asymmetric unit (Z′ = 1) in the space group P212121. Although the crystal structure has been reported before, the determination of the absolute configuration remained uncertain. Stereochemical analysis, including circular dichroism, NMR data and an X-ray diffraction data set with Bijvoet differences, confirms that glabridin, purified from its natural source, is found only in a C3 R configuration. These results can therefore be used as a reference for the assignment of the configuration and enantiopurity of any isolated or synthetic glabridin sample.
Introduction
Glabridin, (I), is a prenylated isoflavan, which has previously been isolated from the roots of Glycyrrhiza glabra (Shibata & Saitoh, 1978 ▶; Zhang & Ye, 2009 ▶). Interestingly, glabridin is one of the most studied licorice flavonoids, and has been widely considered to be a phytoestrogen with numerous biological activities including antioxidant (Vaya et al., 1997 ▶), antibacterial (Fukai et al., 2002 ▶), neuroprotective (Cui et al., 2008 ▶) and potential antitumorogenic properties (Tsai et al., 2010 ▶; Hsu et al., 2011 ▶), as well as antinephritic, antibacterial and skin-whitening activities (Simmler et al., 2013 ▶
a). The structure of glabridin was first characterized in 1976 (Saitoh et al., 1976 ▶) and subsequently more fully investigated by various spectroscopic methods (Kinoshita et al., 1996 ▶; Kim et al., 2009 ▶). The chemical synthesis was reported in 2007 (Yoo & Nahm, 2007 ▶) and the X-ray crystal structure at 293 K was reported last year (Tantishaiyakul et al., 2012 ▶). However, the determination of the absolute stereochemistry and enantiopurity of natural glabridin remains uncertain.
Experimental
Synthesis and crystallization
The CHCl3 extract (4.97 g) from G. glabra roots was fractionated on an HW-40F column (2.5 × 60 cm) with 100% MeOH elution at a flow rate of 2.5 ml min−1, to yield seven fractions. The fourth fraction (1.92 g) was further separated on a Sephadex LH-20 column (1.1 × 9 m) eluted with 100% MeOH at a flow rate of 1 ml min−1, to give a glabridin-enriched fraction (234 mg). The final purification step was carried out on a LiChroCN (1.1 × 30 cm) column using an isocratic elution with CHCl3–MeOH (95:5 v/v). After drying under vacuum, the purified glabridin (10 mg), (I), was dissolved in MeOH–H2O (2.5 ml, 95:5 v/v) and left in a round-bottomed flask at room temperature for 24 h in order to obtain clear colorless crystals.
The 1H NMR spectra (600 MHz in DMSO-d 6 and in CDCl3 at 10 mM) were acquired under quantitative conditions and recorded on a Bruker AVANCE 600 MHz spectrometer equipped with a 5 mm TXI cryoprobe. Off-line data processing was performed using the TOPSPIN 3.0.b.8 software package (Bruker BioSpin GmbH), and PERCH NMR software (Laatikainen et al., 1996 ▶) was employed for the full spin-system analysis. The NMR and circular dichroism (CD; 230–330 nm, in acetonitrile at 50 µM) data obtained for this secondary metabolite were in accordance with previously published data (Kinoshita et al., 1996 ▶; Kim et al., 2009 ▶; Yoo & Nahm, 2007 ▶). Chiral one-dimensional 1H NMR was performed by adding a D2O solution (20 mM) of a chiral reagent {sodium [(R)-1,2-diaminopropane-N,N,N′,N′-tetraacetato]samarate(III) hydrate; TCI Co. Ltd} to the crystalline sample dissolved in DMSO-d 6 (12 mM). Spectra were acquired at 600 MHz. Chiral 1H NMR data processing was done following a Lorentzian-to-Gaussian modification (LB = −2.5 Hz, GF = 0.06), as reported previously (Jaki et al., 2004 ▶). If the sample were to contain two enantiomers, a split in the proton resonance near the chiral center would be observed. The signal split should be all the more significant as the proportion of chiral reagent in the NMR sample increases. The chiral NMR method was previously assessed using a racemic sample of liquiritigenin (Part No. 00012290; Chromadex Inc.), from which the recorded CD spectrum (40 µM in acetonitrile) gave a flat line: 25 µl of samarate solution at 20 mM in D2O added to 200 µl of a liquiritigenin solution at 10 mM in DMSO-d 6 led to splitting of the signals from protons H2 (chiral center) and H3 (adjacent to the chiral center).
Chiral high-performance liquid chromatography (HPLC) was carried out on different types of stationary phases: permethylated B cyclodextrins (Nucleodex β-OH, and α-, β- and γ-PM; Macherey Nagel, GmbH & Co.); sodium magnesium silicate particles and anion exchange with ruthenium (Ceramospher RU-2; Shiseido Co. Ltd); and derivatized cellulose or amylose tris(3,5-dimenthylphenylcarbamate) (Chiralpak 1B and 1A, respectively; Chiral Technolgies, Inc.). Different elution conditions using various solvent mixtures, such as MeOH–H2O, ACN–H2O and n-hexane–EtOH, and various flow rates from 0.7 to 1 ml min−1, were also tested according to the type of stationary phase.
Several crystals were selected and screened, and complete X-ray data sets were collected on the LS-CAT beamline 21-ID-D (APS, Argonne, USA) at 0.7 Å to determine crystal quality. One small colorless crystal was selected for further data collection. An Ewald sphere of intensity data was collected and averaged to a quadrant in the Bravais lattice (Pmmm). The final unit-cell parameters were obtained from refinement using 9904 reflections to a maximum Bragg angle of 68.81°.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1 ▶. The space group was identified as P212121 based upon systematic absences and intensity statistics, with a final total of 2879 unique observations. The positions of the H atoms were evident in a difference electron-density map, and were then freely refined, with U iso(H) = 1.5U eq(parent atom) for hydroxy and methyl H atoms or 1.2U eq(parent atom) otherwise. The structure has been deposited with the Cambridge Crystallographic Data Centre (deposition No. 918747).
Table 1. Experimental details.
| Crystal data | |
| Chemical formula | C20H20O4 |
| M r | 324.36 |
| Crystal system, space group | Orthorhombic, P212121 |
| Temperature (K) | 92 |
| a, b, c (Å) | 6.3744 (10), 11.961 (2), 21.041 (3) |
| V (Å3) | 1604.3 (4) |
| Z | 4 |
| Radiation type | Cu Kα |
| μ (mm−1) | 0.76 |
| Crystal size (mm) | 0.15 × 0.05 × 0.03 |
| Data collection | |
| Diffractometer | Bruker Kappa APEXII DUO CCD area-detector diffractometer |
| Absorption correction | Multi-scan (SADABS; Sheldrick, 2004 ▶) |
| T min, T max | 0.895, 0.978 |
| No. of measured, independent and observed [I > 2σ(I)] reflections | 47918, 2879, 2708 |
| R int | 0.046 |
| (sin θ/λ)max (Å−1) | 0.603 |
| Refinement | |
| R[F 2 > 2σ(F 2)], wR(F 2), S | 0.026, 0.061, 1.03 |
| No. of reflections | 2879 |
| No. of parameters | 277 |
| H-atom treatment | Only H-atom coordinates refined |
| Δρmax, Δρmin (e Å−3) | 0.13, −0.13 |
| Absolute structure | Flack x parameter determined using 1096 quotients [(I +) − (I −)]/[(I +) + (I −)] (Parsons et al., 2013 ▶) |
| Absolute structure parameter | −0.03 (6) |
Results and discussion
After the final step of the medium-pressure liquid chromatography (MPLC) purification process, natural glabridin was crystallized from a mixture of methanol and water to give clear colorless crystals of (I) containing one molecule per asymmetric unit (Z′ = 1) in the space group P212121 (Fig. 1 ▶). A comparison of bond lengths obtained for this and the previous determination is given in the Supplementary materials. An intermolecular hydrogen bond is observed between atom O1B (O1′′ according to the biogenetic labeling) and atom H4A on atom O4A (O4′) of an adjacent molecule, with an O—H⋯O angle of 178 (2)° (Table 2 ▶). In addition, it has been reported (Tantishaiyakul et al., 2012 ▶) that there is a putative O—H⋯π interaction between the hydroxy group on atom O2A and C1A–C6A aromatic ring of a neighboring molecule (Table 2 ▶).
Figure 1.
The hydrogen-bonding scheme of glabridin in the unit cell. Dashed lines indicate hydrogen bonds.
Table 2. Hydrogen-bond geometry (Å, °).
CgA is the centroid of the C1A–C6A ring.
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| O4A—H4A⋯O1B i | 0.86 (3) | 1.96 (3) | 2.8214 (19) | 178 (2) |
| O2A—H2A⋯CgA ii | 0.84 (3) | 2.46 (2) | 3.1505 (16) | 139 (2) |
Symmetry codes: (i)
; (ii)
.
The one-dimensional 1H NMR spectra (600 MHz, in DMSO-d 6 and CDCl3; see Supplementary materials) obtained for the present sample of glabridin are in accordance with previously published data (Kinoshita et al., 1996 ▶; Kim et al., 2009 ▶). The two-dimensional NMR spectra (HSQC and HMBC recorded at 600 MHz in DMSO-d 6) further confirmed the structural assignments. Additionally, the enantiopurity of the crystalline sample has been evaluated by means of chiral HPLC, using different types of stationary phases and elution systems. Under all of these conditions, the glabridin sample eluted only as a single enantiomer. Moreover, chiral 1H NMR in DMSO-d 6 was also performed using a chiral water-soluble reagent (samarate). Even after adding 50% molar concentration of the samarate, no splitting of glabridin 1H NMR signals was observed, suggesting that only one enantiomer was present in the NMR tube. Taken together, these observations suggest that the collected sample was enantiopure.
The stereochemistry of glabridin was determined using Cu Kα radiation and by carefully measuring a large number of Bijvoet differences. We assert that the isolated glabridin crystallized as a pure C3 R enantiomer (Fig. 2 ▶). The Flack parameter (Flack, 1983 ▶) refined to −0.14 (19) for the ‘hole-in-one’ fit, and to −0.03 (6) for the 1096 selected quotients from Parsons’ method (Parsons et al., 2013 ▶). PLATON (Spek, 2009 ▶) was also used to analyze the 1096 Bijvoet differences (Hooft et al., 2008 ▶) and suggested that the glabridin structure is enantiopure: the probability P2 (true) = P3 (true) = 1.000 with P3(racemate-twin) = 5.0 × 10−27, P3 (false) = 1.0 × 10−97, G = 1.09 (10), and the Hooft parameter y = −0.05 (5) for the C3 R enantiomer. CRYSTALS (Betteridge et al., 2003 ▶) was also used to refine the structure. It reported a Flack parameter of −0.13 (16), a G parameter of 1.03 (12) and a Hooft parameter of −0.01 (6).
Figure 2.
The molecular structure of glabridin, showing the atom-labeling scheme according to the crystallographic coordinates. Displacement ellipsoids are drawn at the 50% probability level. The biogenetic labeling scheme relates to the crystallographic atom labels as follows: ‘A’ corresponds to primed (′) labels and ‘B’ corresponds to double primed (′′) labels, e.g. C3A is C3′ and C3B is C3′′.
The determination of absolute structure, and the relative uncertainties in the measurement of the intensities of the Friedel pairs, has been revisited (Flack, 2013 ▶; Parsons et al., 2012 ▶; Flack et al., 2011 ▶). In particular, it has been noted that the average of the observed intensities between Friedel pairs, 2A
o = |F
o(hkl)2| + |F
o(
)2|, can be in good agreement with the corresponding average of the calculated intensities of the model, 2A
c = |F
c(hkl)2| + |F
c(
)2|, but the differences between the observed intensities of the Friedel pairs, D
o = |F
o(hkl)2| − |F
o(
)2|, can be overwhelmed by random and systematic errors in the measurements when compared with the corresponding differences between the calculated intensities of the model, D
c = |F
c(hkl)2| − |F
c(
)2| (Flack, 2013 ▶). Ideally, the plots of 2A
o
versus 2A
c and of D
o
versus D
c would each yield linear fits with slopes of 1 and intercepts at zero. From Fig. 3 ▶(a), we see that 2A
o is in good agreement with 2A
c, with a slope near 1, but this is clearly not true for Fig. 3 ▶(b) with D
o plotted against D
c. However, the slope of the linear fit in Fig. 3 ▶(b) is near 0.2, suggesting a weak resonant-scattering contribution and the correct absolute structure assignment. Indeed, a plot of D
o
versus D
c for D
o > 4σ results in a slope near 0.2 with a correlation coefficient of 0.77 (Fig. 3 ▶
c). Likewise, various assessment factors employing A and D can be defined to ascertain the magnitude of the resonant-scattering contributions to the Friedel pair differences: RA = Σ|2A
o − 2A
c|/Σ|2A
o| = 3.5%, RD = Σ|D
o − D
c|/Σ|D
o| = 92.0%, RAD = Σ|D
o|/Σ|A
o| = 1.5% and 〈D
o/σ〉 = (1/n)Σ|D
o|/σ = 1.9. These assessment factors suggest that the resonant-scattering contributions to the observed intensities are weak, but still significant enough to assign the absolute structure correctly.
Figure 3.
2A and D plots of (a) 2A o versus 2A c, (b) D o versus D c for all data and (c) D o versus D c for all Friedel pairs with D o > 4σ.
Circular dichroism (CD) of flavonoids can indicate the configuration of a sample regardless of its enantiopurity (Slade et al., 2005 ▶). If a sample is defined by an enantiomeric excess, its CD spectrum will only indicate the configuration of the enantiomer present in excess (Simmler et al., 2013 ▶ b). Given that the enantiopurity and stereochemistry of the present glabridin sample have been determined by means of complementary techniques (chiral HPLC, NMR and X-ray diffraction), the CD spectrum recorded from the crystalline sample (50 µM in acetonitrile) displays the molecular ellipticity of an enantiopure glabridin in a C3 R configuration (Kim et al., 2009 ▶) (Fig. 4 ▶).
Figure 4.
The CD spectrum of C3 R enantiopure glabridin at 50 µM in acetonitrile.
Conclusions
The present description of the crystal structure of glabridin complements existing spectroscopic data, and confirms that glabridin naturally occurs in the C3 R configuration. From this stereochemical point of view, it is important to consider that all the biological activities reported for natural glabridin are likely obtained from the R enantiomer. Therefore, the reported CD spectrum can be used as a reference for further characterization and elucidation of the enantiopurity of an isolated or synthetic glabridin sample. The results presented herein provide an unequivocal foundation for the structural characterization of this phytochemical and biological marker of European licorice, G. glabra L.
Supplementary Material
Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S0108270113018842/ln3162sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S0108270113018842/ln3162Isup2.hkl
Supporting information file. DOI: 10.1107/S0108270113018842/ln3162Isup3.cdx
Supporting information file. DOI: 10.1107/S0108270113018842/ln3162Isup4.cml
Acknowledgments
This research was supported by NCCAM and ODS through grant No. P50 AT000155. The authors acknowledge use of the Life Sciences Collaborative Access Team (LS-CAT) beamline 21-ID-D for the initial data collection; use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Upgrade of the diffractometer was made possible by grant No. LEQSF(2011–12)-ENH-TR-01, administered by the Louisiana Board of Regents. Finally, we thank Dr José Napolitano, UIC Chicago (Illinois), and Matthias Niemitz, Perch Solutions Ltd, Kuopio (Finland), for helpful NMR discussions and PERCH support.
Footnotes
Supplementary data for this paper are available from the IUCr electronic archives (Reference: LN3162). Services for accessing these data are described at the back of the journal.
References
- Betteridge, P. W., Carruthers, J. R., Cooper, R. I., Prout, K. & Watkin, D. J. (2003). J. Appl. Cryst. 36, 1487.
- Bruker (2007). APEX2 and SAINT Bruker AXS Inc., Madison, Wisconsin, USA.
- Cui, Y.-M., Ao, M.-Z., Li, W. & Yu, L.-J. (2008). Planta Med. 74, 377–380. [DOI] [PubMed]
- Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
- Flack, H. D. (1983). Acta Cryst. A39, 876–881.
- Flack, H. D. (2013). Acta Cryst. C69, 803–807. [DOI] [PubMed]
- Flack, H. D., Sadki, M., Thompson, A. L. & Watkin, D. J. (2011). Acta Cryst. A67, 21–34. [DOI] [PubMed]
- Fukai, T., Marumo, A., Kaitou, K., Kanda, T. & Nomura, T. (2002). Life Sci. 71, 1449–1463. [DOI] [PubMed]
- Hooft, R. W. W., Straver, L. H. & Spek, A. L. (2008). J. Appl. Cryst. 41, 96–103. [DOI] [PMC free article] [PubMed]
- Hsu, Y.-L., Wu, L.-Y., Hou, M.-F., Tsai, E.-M., Lee, J.-N., Liang, H.-L., Jong, Y.-J., Hung, C.-H. & Kuo, P.-L. (2011). Mol. Nutr. Food Res. 55, 318–327. [DOI] [PubMed]
- Jaki, B., Franzblau, S. G. & Pauli, G. F. (2004). Phytochem. Anal. 15, 213–219. [DOI] [PubMed]
- Kim, M., Kim, S.-U., Kim, Y.-U. & Han, J. (2009). Bull. Korean Chem. Soc. 30, 415–418.
- Kinoshita, T., Kajiyama, K., Hiraga, Y., Takahashi, K., Tamura, Y. & Mizutani, K. (1996). Heterocycles, 83, 581–588.
- Laatikainen, R., Niemitz, M., Weber, U., Sundelin, J., Hassinen, T. & Vepsäläinen, J. (1996). J. Magn. Reson. 120, 1–10.
- Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
- Parsons, S., Pattison, P. & Flack, H. D. (2012). Acta Cryst. A68, 736–749. [DOI] [PubMed]
- Saitoh, T., Kinoshita, T. & Shibata, S. (1976). Chem. Pharm. Bull. 24, 752–754.
- Sheldrick, G. M. (2004). SABABS University of Göttingen, Germany.
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Shibata, S. & Saitoh, T. (1978). J. Indian Chem. Soc. 55, 1184–1191.
- Simmler, C., Pauli, G. F. & Chen, S.-N. (2013a). Fitoterapia, 90, 160–184. [DOI] [PMC free article] [PubMed]
- Simmler, C., Hajirahimkhan, A., Lankin, D. C., Bolton, J. L., Jones, T., Soejarto, D. D., Chen, S.-N. & Pauli, G. F. (2013b). J. Agric. Food Chem. 61, 2146–2157. [DOI] [PMC free article] [PubMed]
- Slade, D., Ferreira, D. & Marais, J. P. J. (2005). Phytochemistry, 66, 2177–2215. [DOI] [PubMed]
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
- Tantishaiyakul, V., Suknuntha, K., Saithong, S. & Pakawatchai, C. (2012). Acta Cryst. E68, o3501. [DOI] [PMC free article] [PubMed]
- Tsai, Y.-M., Yang, C.-J., Hsu, Y.-L., Wu, L.-Y., Tsai, Y.-C., Hung, J.-Y., Lien, C.-T., Huang, M.-S. & Kuo, P.-L. (2010). Integr. Cancer Ther. 20, 1–9. [DOI] [PubMed]
- Vaya, J., Belinky, P. A. & Aviram, M. (1997). Free Radical Biol. Med. 23, 302–313. [DOI] [PubMed]
- Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.
- Yoo, S.-K. & Nahm, K. (2007). Bull. Korean Chem. Soc. 28, 481–484.
- Zhang, Q. & Ye, M. (2009). J. Chromatogr. A, 1216, 1954–1969. [DOI] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S0108270113018842/ln3162sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S0108270113018842/ln3162Isup2.hkl
Supporting information file. DOI: 10.1107/S0108270113018842/ln3162Isup3.cdx
Supporting information file. DOI: 10.1107/S0108270113018842/ln3162Isup4.cml




